Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Debra H. Schussheim"'
Autor:
Elizabeth Shane, Mishaela R. Rubin, Carolina A. M. Kulak, John P. Bilezikian, Etah S. Kurland, Debra H. Schussheim, Clifford J. Rosen
Publikováno v:
Osteoporosis International. 16:526-533
Although osteoporosis predominantly affects older postmenopausal women, low bone mineral density also occurs in men and younger women. In men, it is often unexplained by recognized secondary causes. These men with idiopathic osteoporosis have reducti
Publikováno v:
Endocrine Practice. 9:36-39
Objective To discuss a case of idiopathic low bone density in a young woman. Methods We present a detailed report that includes clinical, laboratory, and radiologic assessment of a premenopausal woman with idiopathic low bone mass. Results A 34-year-
Autor:
A. Lee Burns, Allen M. Spiegel, William F. Simonds, Monica C. Skarulis, Debra H. Schussheim, Sunita K. Agarwal, Stephen J. Marx
Publikováno v:
Trends in Endocrinology & Metabolism. 12:173-178
Multiple endocrine neoplasia type 1 (MEN1) provides a prime example of how a rare disease can advance our understanding of basic cell biology, neoplasia and common endocrine tumors. MEN1 is expressed mainly as parathyroid, enteropancreatic neuroendoc
Autor:
Edward H. Oldfield, Sunita K. Agarwal, Robert J. Weil, Stephen J. Marx, Debra H. Schussheim, Monica C. Skarulis, Samuel M. Freedman, Svetlana Pack, Irina A. Lubensky, Zhengping Zhuang, Constantine A. Stratakis, Margaret F. Keil
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 85:4776-4780
Multiple endocrine neoplasia type 1 (MEN 1) is associated with parathyroid, enteropancreatic, pituitary, and other tumors. The MEN1 gene, a tumor suppressor, is located on chromosome 11. Affected individuals inherit a mutated MEN1 allele, and tumorig
Autor:
Aliya Khan, Zareen Syed, John P. Bilezikian, Atif M. Shaikh, Sacha Dubois, Andrew Y. Y. Ho, Mishaela R. Rubin, Debra H. Schussheim, Timothy I. Standish, Shonni J. Silverberg, Annie W. C. Kung, Mustafa M. Ahmed, Zeba A. Syed
Publikováno v:
The Journal of clinical endocrinology and metabolism. 89(7)
Primary hyperparathyroidism (PHPT) is often associated with reduced bone mineral density (BMD). A randomized, double-blind, placebo-controlled trial was conducted to determine whether alendronate (ALN), 10 mg daily, maintains or improves BMD in patie
Autor:
Debra H. Schussheim, John P. Bilezikian, Shonni J. Silverberg, Elizabeth Shane, Etah Kurland, Carolina A. Moreira Kulak, Donald J. McMahon, Ethel S. Siris
Publikováno v:
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists. 6(4)
To characterize the historical, clinical, and biochemical features of 111 young women (age,55 years) referred for evaluation of osteoporosis or low bone mass.Women with a bone mineral density T scoreor = -2.0 (N = 111) at one or more anatomic sites (
Autor:
John J.B. Anderson, Merredith August, Daniel T. Baran, David J. Baylink, Belinda Beck, Norman H. Bell, Paolo Bianco, John P. Bilezikian, Jean-Philippe Bonjour, Mary L. Bouxsein, David B. Burr, Dennis R. Carter, Juliet Compston, Felicia Cosman, Deborah Cardamone Cusatis, Leah Rae Donahue, Thomas A. Einhorn, Murray J. Favus, Kathleen Forti-Gallant, L.J. Fraher, F. Michael Gloth, Julie Glowacki, Deborah T. Gold, Caren M. Gundberg, Robert P. Heaney, A.B. Hodsman, Mark C. Horowitz, Leonard B. Kaban, Dike N. Kalu, L. Lyndon Key, Douglas P. Kiel, Peter Lakatos, K.-H. William Lau, Meryl S. LeBoff, Peter Leong, Robert Lindsay, Loren G. Lipson, Tom Lloyd, Kenneth W. Lyles, Robert Marcus, Carlos A. Mautalen, Jeffrey D. Moffett, Subburaman Mohan, Douglas B. Muchmore, Dorothy A. Nelson, Michael C. Nevitt, Beatriz Oliveri, Eric Orwoll, Sacrates E. Papapoulos, R.L. Prince, Lawrence G. Raisz, René Rizzoli, Pamela Gehron Robey, Simon P. Robins, Clifford J. Rosen, Philip D. Ross, Clinton Rubin, Harry Rubin, Janet Rubin, Arthur Santora, Debra H. Schussheim, Ego Seeman, Markus J. Seibel, Sherry Sherman, Shonni J. Silverberg, Mehrsheed Sinaki, Ethel S. Siris, Paula H. Stern, John L. Stock, Thomas S. Thornhill, Charles H. Turner, Marjolein C.H. van der Meulen, Marie Luz Villa, Michelle P. Warren, Richard C. Wasnich, P.H. Watson, Catherine E. Wand, Jonathan M. Weiner, Mark L. Weiss, Mitchell J. Winemaker, A. John Yates
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c6d46979e983bfbab2fa8bde7db67cd4
https://doi.org/10.1016/b978-012098655-2/50000-4
https://doi.org/10.1016/b978-012098655-2/50000-4
Selective estrogen receptor modulators (SERMs) constitute a group of chemical compounds that are distinct from estrogen. The ideal SERM would provide an estrogen-like effect at bone, preserving bone mass and reducing the risk of osteoporotic fracture
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::44cc97e7fdd81a4cc012f39d8bff9da1
https://doi.org/10.1016/b978-012098655-2/50044-2
https://doi.org/10.1016/b978-012098655-2/50044-2
Autor:
Debra H Schussheim, Adam E. Schussheim
Publikováno v:
Lancet (London, England). 351(9117)
Publikováno v:
Annals of Internal Medicine. 130:329